Autoimmune Diseases

Low-to-moderate doses of prednisone appear to lessen rates of nausea and other side effects in patients taking methotrexate, a new study found.

Stimulating PD-1 is a novel approach to treating rheumatoid arthritis, but the strategy could be a fit for other autoimmune diseases.

Merck will withdraw Keytruda's advanced gastric indication after an FDA panel vote, a drug with supply problems gets a new indication, NDAs for an HIV therapy, and other news.

Telehealth during the COVID-19 pandemic has been especially important to patients with rare disorders, many of which are autoimmune diseases, according to a recent report from the National Organization for Rare Disorders.

New data presented recently at the American College of Rheumatology meeting add to the evidence in support of anifrolumab, which could address unmet need in lupus.

Rather than stopping hydroxychloroquine altogether, doses could be reduced and patients monitored if there are signs of retinopathy, say the authors of a commentary in the American Journal of Ophthalmology.

Central obesity may be especially unhealthy for people with the inflammatory condition that affects the spine.

Research documents that the disease affects men and women differently.

An immunotherapy combination gets a third thoracic indication; another potential indication for an SGLT2 inhibitor.

Fatigue causes a complex array of problems for people with autoimmune disease.

Study of the quality of life of psoriatic arthritis patients reveals the added burden of skin symptoms.

FDA actions for the week ending August 21, 2020, include a hearing set for a drug that could limit weight gain often associated with treatment for serious mental illness.

Celiac disease was linked with a greater likelihood to be diagnosed with a mood disorder, ADHD, or an eating disorder.

A recent study found 64% of patients with psoriatic arthritis who had tried at least one biologic stayed with Cosentyx for the entire study period.

Preliminary findings by Case Western researchers point to kallikrein-related peptidase 6 as possible culprit in the development of psoriatic arthritis.

Potential agents to battle inflammation and other processes move through development pipeline.

A look at recent developments in treatment and the cost implications of various autoimmune diseases.

The food people eat and the toxins they are exposed to on a daily basis are two of the biggest contributors to the likelihood of developing an autoimmune disease, according to many health experts.

Protein produced by common gut bacteria may trigger the onset of autoimmune diseases such as multiple sclerosis, rheumatoid arthritis, and ulcerative colitis.

Although it’s still unknown what the mechanisms are that contribute to MS-related fatigue, certain dietary approaches can help treat it.

A Yale University study has revealing findings about how diet impacts patients with lupus.

A new Chinese study highlights a potential cell therapy strategy for autoimmune diseases in a clinic setting.

A new study theorizes organs affected by autoimmune disease suppress immune cells using methods similar to those used by cancer cells to evade detection.

Results of 20-year cohort study reveal that women with history of this serious medical illness are more vulnerable to lupus.

New research has revealed that this approach could aid in the treatment of autoimmune diseases, as well as help with diabetes, chronic pain and numerous other conditions.

A new Swedish study examined gender differences in rheumatism and other autoimmune diseases. Here are the surprising findings.

A new study has surprising findings about traumatic or stressful life events and the link to developing an autoimmune disease.

A South Korean study may contribute to the improvement of personalized therapeutic outcomes for rheumatoid arthritis by expanding the scope of molecular imaging.

A new study on the overlap between the causes of rheumatoid arthritis and Huntington’s disease opens up new therapeutic targets and drugs for both conditions.

A neurologist and autoimmune expert at UT Southwestern shares insight into using large biobanks to understand and treat this rare autoimmune disease.